Citation

86 FR 33326

Canonical document for this Federal Register citation.

Prospective Grant of an Exclusive Patent License: Development and Commercialization of Monospecific CD22 Chimeric Antigen Receptor (CAR) Therapies for the Treatment of B-Cell Malignancies Thursday, June 24, 2021 86 FR 33326